Journal
CLINICAL AND MOLECULAR HEPATOLOGY
Volume 20, Issue 3, Pages 317-326Publisher
KOREAN ASSOC STUDY LIVER
DOI: 10.3350/cmh.2014.20.3.317
Keywords
Chemotherapy; Hepatic toxicity; Pseudocirrhosis; Steatosis; Hepatic Necrosis; Hepatitis
Categories
Ask authors/readers for more resources
Treating patients undergoing chemotherapy who display findings of liver toxicity, requires a solid understanding of these medications. It is important for any clinician to have an index of suspicion for liver toxicity and be able to recognize it, even on imaging. Cancer chemotherapy has evolved, and newer medications that target cell biology have a different pattern of liver toxicity and may differ from the more traditional cytotoxic agents. There are several hepatic conditions that can result and keen clinical as well as radiographic recognition are paramount. Conditions such as sinusoidal obstructive syndrome, steatosis, and pseudocirrhosis are more commonly associated with chemotherapy. These conditions can display clinical signs of acute hepatitis, liver cirrhosis, and even liver failure. It is important to anticipate and recognize these adverse reactions and thus appropriate clinical action can be taken. Often times, patients with these liver manifestations can be managed with supportive therapies, and liver toxicity may resolve after discontinuation of chemotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available